Kite

For an 'acquisitive' Gilead, 2020 will be key test for CAR-T plans
Biopharma Dive
Tue, 12/10/19 - 11:51 pm
M&A
Gilead Sciences
Kite
Top Presentations to Look for at ASCO
Yahoo/24-7 Wall St
Tue, 05/30/17 - 11:35 am
ASCO 2017
Merck
AbbVie
Eli Lilly
Bluebird Bio
Epizyme
Juno Therapeutics
Kite
Merus
Cancer Conference Winners And Losers
Forbes
Mon, 06/2/14 - 10:38 am
ASCO
GSK
Puma Biotechnology
Merck
Roche
Bristol-Myers Squibb
Kite
Novartis
Juno Therapeutics
Eli Lilly
Clovis Oncology
AstraZeneca